ORMP
Oramed Pharmaceuticals Inc
4.70$
-1.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +13,883.3% | +999.4% | +184.3% | -40.8% | -55.5% | +198.2% | +22.4% | +63.6% | +151.7% | +20.9% | +62.5% | -9.6% | +22.4% | -26.9% | +28.8% | +186.8% | +26.3% | +36.4% | -29.6% | +48.7% | |
| – | – | +13,883.3% | +995.4% | +179.7% | -41.2% | -56.0% | +206.7% | +23.2% | +63.8% | +151.9% | -20.2% | +79.8% | -35.0% | +52.9% | +7.4% | +21.6% | +135.3% | +64.8% | +3.5% | -11.9% | -6.9% | |
| – | – | – | +988.6% | +18.2% | -24.3% | -30.1% | +26.2% | +192.8% | -48.7% | -22.5% | +82.3% | +21.6% | +1.6% | +25.9% | -33.4% | +479.6% | +300.3% | -47.6% | -77.6% | +501.0% | -15.6% | |
| – | – | – | +988.6% | +160.4% | -45.6% | -52.2% | +46.0% | +144.0% | +83.0% | +151.2% | -19.1% | +80.0% | -35.1% | +51.4% | +6.0% | +23.6% | +135.9% | +65.4% | +4.1% | -12.4% | -11.3% | |
| – | – | – | – | – | – | -83.6% | +691.9% | -84.5% | -28.6% | +548.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -1.1% | +3.6% | -12.6% | +0.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +360.7% | +1,221.8% | +133.9% | -35.8% | -43.6% | +20.4% | -3.0% | +152.0% | -65.1% | +90.6% | +51.2% | +990.4% | +17.0% | -16.4% | -6.2% | -23.0% | -2.3% | -8.7% | +449.9% | -82.8% | +213.4% | |
| – | +360.7% | +1,221.8% | +133.9% | -35.8% | -59.7% | +24.4% | -3.8% | +46.0% | -22.7% | +95.3% | +53.0% | +143.2% | +42.6% | -11.8% | +16.6% | -14.5% | +47.2% | -14.0% | +826.1% | -89.3% | +235.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +195.5% | +90.0% | +20,661.1% | -99.6% | +31.9% | |
| – | – | +852.5% | +535.6% | +168.0% | -94.8% | +0.0% | +0.0% | +0.0% | +830.2% | +110.7% | +2.9% | +48.1% | -59.5% | +98.8% | +17.8% | -55.6% | +338.7% | -16.5% | -74.7% | +43.2% | -43.9% | |
| – | – | – | – | +795.3% | -40.2% | -69.8% | +348.5% | +1.5% | +115.2% | +155.7% | +19.4% | +5.5% | -26.5% | +61.7% | -37.7% | +69.5% | +252.1% | +31.1% | +7.9% | -10.7% | +36.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -37.9% | -57.5% | +26.7% | +14.9% | +16.5% | +1.3% | +13.3% | +8.6% | +22.5% | +28.2% | +17.1% | +16.7% | +5.4% | +11.8% | +17.3% | +17.6% | +38.7% | +37.0% | +4.0% | +0.7% | +3.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.